We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Estee Lauder
EL
$30.7B
| $2.86M | 0.01% |
14,547
+3,485
| +32% | +$739K |
|
302
Occidental Petroleum
OXY
$53.6B
| $2.81M | 0.01% |
47,856
-99,662
| -68% | -$5.98M |
|
303
Biohaven
BHVN
$2.07B
| $2.77M | 0.01% |
115,672
-52,175
| -31% | -$898K |
|
304
Simon Property Group
SPG
$76.8B
| $2.7M | 0.01% |
23,357
| – | – |
|
305
Pfizer
PFE
$144B
| $2.68M | 0.01% |
73,022
| – | – |
|
306
Match Group
MTCH
$9.16B
| $2.67M | 0.01% |
+63,822
| New | +$2.33M |
|
307
Altria Group
MO
$125B
| $2.67M | 0.01% |
58,854
| – | – |
|
308
RB Global
RBA
$21.7B
| $2.65M | 0.01% |
44,154
-1,088
| -2% | -$61.3K |
|
309
Stevanato
STVN
$5.5B
| $2.64M | 0.01% |
81,529
+16,013
| +24% | +$450K |
|
310
Prologis
PLD
$137B
| $2.61M | 0.01% |
21,262
| – | – |
|
311
Bristol-Myers Squibb
BMY
$130B
| $2.57M | 0.01% |
40,225
| – | – |
|
312
Penumbra
PEN
$12.6B
| $2.57M | 0.01% |
7,458
-428
| -5% | -$131K |
|
313
Viridian Therapeutics
VRDN
$2.15B
| $2.55M | 0.01% |
107,318
-216,358
| -67% | -$5.55M |
|
314
lululemon athletica
LULU
$13.7B
| $2.55M | 0.01% |
6,735
-10,875
| -62% | -$4.01M |
|
315
Edwards Lifesciences
EW
$48.2B
| $2.53M | 0.01% |
26,802
+25,962
| +3,091% | +$2.26M |
|
316
ProPetro Holding
PUMP
$1.31B
| $2.52M | 0.01% |
306,388
-7,467
| -2% | -$54.8K |
|
317
Seacoast Banking Corp of Florida
SBCF
$3.27B
| $2.5M | 0.01% |
113,068
-88,465
| -44% | -$1.92M |
|
318
Vail Resorts
MTN
$5.6B
| $2.5M | 0.01% |
9,913
-154
| -2% | -$37.5K |
|
319
TripAdvisor
TRIP
$1.74B
| $2.49M | 0.01% |
150,776
-3,771
| -2% | -$63.8K |
|
320
Sempra
SRE
$59.2B
| $2.48M | 0.01% |
34,042
| – | – |
|
|
FNA
321
DELISTED
Paragon 28, Inc.
FNA
| $2.45M | 0.01% |
138,219
-3,321
| -2% | -$59.7K |
|
322
Affiliated Managers Group
AMG
$9.78B
| $2.45M | 0.01% |
16,344
-492
| -3% | -$70.4K |
|
323
Welltower
WELL
$172B
| $2.41M | 0.01% |
29,825
| – | – |
|
324
Medtronic
MDT
$111B
| $2.4M | 0.01% |
27,259
| – | – |
|
325
Sysco
SYY
$40.7B
| $2.38M | 0.01% |
32,116
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.